PBH Prestige Consumer Healthcare Inc. Common Stock
$52,05
السعر · أغسطس 19, 2026
البيانات الأساسية اعتبارًا من أغسطس 6, 2026
نطاق 52 أسبوعًا
$43–$71
33% of range
تقييم المحللين
BUY
10 analysts
السعر المستهدف
$68
+30% upside
P/E (TTM)
13.3
ROE
10.2%
هامش صافي الربح
17.5%
حول Prestige Consumer Healthcare Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا
Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
اقرأ المزيد
Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.
Among the brands owned by Prestige are Chloraseptic sore throat products, Clear Eyes, Compound W wart treatment, Dramamine motion sickness treatment, Efferdent denture care, Luden's throat drops, BC Powder and Goody's Headache Powder, Pediacare & Little Remedies children's OTC products and Beano (dietary supplement).
The company's CEO and president is Ron Lombardi, who replaced Matthew Mannelly on June 1, 2015.
History
Prestige Brands Holdings, Inc. was established in 1999 to acquire, revitalize, and line extend leading, often neglected but healthy brands that were considered non-core at major consumer products companies. In 2004, MidOcean Partners sold Prestige Brands to GTCR Golder Rauner.
Acquisitions
The company acquired Blacksmith Brands' portfolio of five brands in 2010.
In December 2011, the company agreed to purchase 17 brands from GlaxoSmithKline including BC Powder, Beano, Ecotrin, Fiber Choice, Goody's Powder, Sominex and Tagamet for $660 million.
In 2013, Prestige Brands Holdings, Inc. acquired Care Pharmaceuticals of Bondi Junction, New South Wales, Australia, a privately held marketer and distributor of over-the-counter (OTC) healthcare brands for children and adults.
In 2014, the company purchased Hydralyte in Australia and New Zealand from the Hydration Pharmaceuticals Trust of Victoria, Australia. Hydralyte is the leading oral rehydration product in Australia and New Zealand.
In April 2014, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire Insight Pharmaceuticals Corporation, a marketer and distributor of feminine care and other over-the-counter healthcare products, for $750 million in cash.
In November 2015, Prestige Brands Holdings, Inc. announced that it has entered into a definitive agreement to acquire DenTek Oral Care Inc. (DenTek), a privately held marketer and distributor of oral care products for $225 million in cash.
In December 2016, Prestige Brands Holdings, Inc. agreed to buy C.B. Fleet Co. from private-equity firm Gryphon Investors for about $825 million.
In July 2021, consumer health business assets were acquired from Akorn Operating Company, LLC for $228.9 million adding TheraTears and other products to their brands.
Divestitures
In 2009, Prestige sold its Denorex and Prell brands of shampoo. It has since divested Fiber Choice, PediaCare, New-Skin, and Dermoplast (2016).
In 2018, Prestige sold off their household cleaning supply division.
Products
Prestige Consumer Healthcare owns many over-the counter medicines and products, including:
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
PBH لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$52.05
القيمة السوقية
$2.93B
P/E (TTM)
13.3
ربح السهم (آخر 12 شهرًا)
$3.91
الإيرادات (آخر 12 شهرًا)
$1.09B
عائد التوزيعات
—
ROE
10.2%
D/E الدين/حقوق الملكية
—
نطاق 52 أسبوعًا
$43 – $71
PBH مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$1.09B
2017-03-31
→
2026-03-31
ربح السهم
$3.91
2017-03-31
→
2026-03-31
التدفق النقدي الحر
$246M
2017-03-31
→
2026-03-31
الهوامش
17.5%
2017-03-31
→
2026-03-31
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
PBH
متوسط الأقران
P/E (TTM)
13.3
29.4
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
2.7
4.9
P/B (السعر / القيمة الدفترية)
1.6
6.5
Price / FCF (السعر / التدفق النقدي الحر)
11.9
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
PBH
متوسط الأقران
Gross Margin (هامش الربح الإجمالي)
54.7%
82.8%
Operating Margin (هامش التشغيل)
28.4%
—
Net Profit Margin (هامش صافي الربح)
17.5%
-9.0%
ROA (العائد على الأصول)
5.5%
-8.2%
ROE
10.2%
-19.4%
ROIC
12.1%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
PBH
متوسط الأقران
Current Ratio (النسبة الحالية)
3.6
3.6
Quick Ratio (النسبة السريعة)
2.1
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
PBH
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
-4.3%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
-1.2%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
2.9%
—
EPS YoY (ربحية السهم على أساس سنوي)
-8.9%
—
Net Income YoY (صافي الدخل مقارنة بالعام السابق)
-11.3%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
PBH
متوسط الأقران
PBH توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
10 محللين
- شراء قوي 3 30,0%
- شراء 4 40,0%
- احتفاظ 3 30,0%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
5 محللين · 2026-08-15
الوسيط
$70.00
المتوسط
$67.80
← أقل من جميع الأهداف
$52.05
منخفض
$55.00
مرتفع
$75.00
السعر المستهدف الوسيط
$70.00
+34,5%
السعر المستهدف المتوسط
$67.80
+30,3%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
-0.01%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $0.98 | $0.89 | 0.09% |
| 31 مارس، 2026 | $1.23 | $1.40 | -0.17% |
| 31 ديسمبر، 2025 | $1.14 | $1.16 | -0.02% |
| 30 سبتمبر، 2025 | $1.07 | $0.98 | 0.09% |
| 30 يونيو، 2025 | $0.95 | $1.01 | -0.06% |
| 31 مارس، 2025 | $1.32 | $1.31 | 0.01% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| RAPP | $1.45B | -10.6 | — | — | -29.8% | — |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | — |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 17
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Cost of Revenue | $493M | $503M | $501M | $502M | $466M | $396M | $411M | $420M | $465M | $382M | $339M | · | |
| Gross Profit | $596M | $634M | $624M | $625M | $621M | $547M | $552M | $556M | $577M | $500M | $467M | $406M | |
| SG&A Expense | $116M | $108M | $106M | $107M | $107M | $83M | $89M | $90M | $85M | $89M | $72M | $81M | |
| Operating Expenses | $286M | $298M | $282M | $648M | $291M | $250M | $261M | $488M | $361M | $295M | $207M | $199M | |
| Operating Income | $309M | $337M | $342M | $-22M | $330M | $297M | $291M | $68M | $215M | $206M | $260M | $208M | |
| Interest Expense | · | $2M | $5M | $4M | · | · | · | · | · | · | · | · | |
| Interest Income | · | · | · | · | · | · | $342.0K | $217.0K | $388.0K | $203.0K | $162.0K | $92.0K | |
| Other Non-op | $-10M | $-5M | $756.0K | $-2M | $-1M | $1M | $-2M | $-476.0K | $392.0K | $-30.0K | · | · | |
| Pretax Income | $257M | $284M | $276M | $-94M | $262M | $204M | $191M | $-38M | $107M | $111M | $157M | $127M | |
| Income Tax | $67M | $70M | $67M | $-12M | $57M | $39M | $49M | $-2M | $-232M | $41M | $57M | $49M | |
| Net Income | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| EPS (Basic) | $3.93 | $4.32 | $4.21 | $-1.65 | $4.09 | $3.28 | $2.81 | $-0.69 | $6.40 | $1.31 | $1.89 | $1.50 | |
| EPS (Diluted) | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 | $1.88 | $1.49 | |
| Shares (Basic) | 48,456,000 | 49,697,000 | 49,757,000 | 49,889,000 | 50,259,000 | 50,210,000 | 50,723,000 | 52,068,000 | 53,099,000 | 52,976,000 | 52,754,000 | 52,170,000 | |
| Shares (Diluted) | 48,720,000 | 50,080,000 | 50,178,000 | 49,889,000 | 50,842,000 | 50,605,000 | 51,140,000 | 52,068,000 | 53,526,000 | 53,362,000 | 53,143,000 | 52,670,000 | |
| EBITDA | $341M | $367M | $373M | $10M | $362M | $328M | $320M | $99M | $249M | $231M | $284M | $225M |
الميزانية العمومية 29
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $98M | $46M | $58M | $27M | $32M | $95M | $28M | $33M | $42M | $27M | $21M | |
| Receivables | $192M | $194M | $177M | $167M | $139M | $115M | $151M | $149M | $141M | $137M | $95M | $88M | |
| Inventory | $159M | $148M | $139M | $162M | $120M | $115M | $116M | $120M | $119M | $116M | $91M | $74M | |
| Prepaid Expense | $17M | $8M | $13M | $4M | $6M | $8M | $4M | $5M | $12M | $40M | $25M | $10M | |
| Current Assets | $431M | $448M | $375M | $392M | $293M | $270M | $366M | $301M | $303M | $334M | $249M | $202M | |
| PP&E (Net) | $122M | $75M | $77M | $70M | $71M | $70M | $56M | $51M | $53M | $51M | $16M | $14M | |
| PP&E (Gross) | $211M | $156M | $149M | $137M | $132M | $124M | $102M | $90M | $83M | $71M | $30M | $26M | |
| Accum. Depreciation | $89M | $81M | $72M | $67M | $61M | $54M | $46M | $39M | $30M | $20M | $15M | $12M | |
| Goodwill | $581M | $527M | $528M | $528M | $579M | $578M | $575M | $579M | $620M | $615M | $360M | $291M | |
| Intangibles | $2.30B | $2.30B | $2.32B | $2.34B | $2.70B | $2.48B | $2.48B | $2.51B | $2.78B | $2.90B | $2.32B | $2.13B | |
| Other Non-current Assets | $11M | $3M | $6M | $3M | $3M | $3M | $3M | $3M | $4M | $7M | $1M | $1M | |
| Total Assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Accounts Payable | $23M | $19M | $39M | $63M | $56M | $46M | $62M | $57M | $61M | $70M | $38M | $46M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $41M | |
| Current Liabilities | $121M | $107M | $117M | $161M | $143M | $122M | $150M | $127M | $123M | $162M | $107M | $99M | |
| Capital Leases | $21M | $23M | $8M | $10M | $16M | $20M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $447M | $420M | $404M | $380M | $445M | $434M | $408M | $400M | $443M | $715M | $470M | $352M | |
| Other Non-current Liabilities | $6M | $5M | $9M | $8M | $7M | $9M | $25M | $20M | $23M | $18M | $3M | $2M | |
| Total Liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B | $2.07B | $2.34B | $2.35B | $2.58B | $3.09B | $2.20B | $2.01B | |
| Long-term Debt | $994M | $992M | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | · | · | $1.56B | |
| Total Debt | · | · | $1.13B | $1.35B | $1.48B | $1.48B | $1.73B | $1.80B | $1.99B | $2.19B | $1.63B | $1.59B | |
| Common Stock | $562.0K | $560.0K | $555.0K | $548.0K | $544.0K | $540.0K | $538.0K | $536.0K | $534.0K | $533.0K | $530.0K | $525.0K | |
| Paid-in Capital | $609M | $593M | $567M | $535M | $516M | $500M | $488M | $479M | $469M | $458M | $445M | $427M | |
| Retained Earnings | $1.75B | $1.56B | $1.34B | $1.13B | $1.21B | $1.01B | $844M | $702M | $736M | $397M | $327M | $227M | |
| Treasury Stock | $439M | $277M | $220M | $189M | $134M | $131M | $118M | $60M | $8M | $7M | $5M | $3M | |
| AOCI | $-28M | $-38M | $-34M | $-32M | $-19M | $-20M | $-44M | $-26M | $-19M | $-26M | $-24M | $-23M | |
| Stockholders' Equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B | $1.36B | $1.17B | $1.10B | $1.18B | $823M | $744M | $628M | |
| Liabilities + Equity | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B | $3.51B | $3.44B | $3.76B | $3.91B | $2.95B | $2.64B | |
| Shares Outstanding | 56,211,000 | 56,010,000 | 55,501,000 | 54,857,000 | 54,430,000 | 53,999,000 | 53,805,000 | 53,670,000 | 53,396,000 | 53,287,000 | 53,066,000 | 52,562,000 |
التدفق النقدي 16
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $31M | $30M | $31M | $33M | $32M | $30M | $29M | $32M | $33M | $26M | $24M | $18M | |
| Stock-based Comp | $11M | $11M | $14M | $12M | · | · | · | · | · | $8M | $10M | $7M | |
| Deferred Tax | $23M | $14M | $23M | $-61M | $10M | $19M | $14M | $-41M | $-269M | $-6M | $46M | $29M | |
| Amort. of Intangibles | $18M | $18M | $20M | $22M | $21M | $20M | $20M | $22M | $23M | $20M | $18M | $13M | |
| Other Non-cash | $3M | $-19M | $-14M | $340M | $12M | $22M | $32M | $234M | $106M | $50M | $-5M | $24M | |
| Operating Cash Flow | $258M | $252M | $249M | $230M | $260M | $236M | $217M | $189M | $210M | $149M | $176M | $156M | |
| CapEx | $11M | $8M | $10M | $8M | $10M | $22M | $15M | $10M | $13M | $3M | $4M | $6M | |
| Investing Cash Flow | $-137M | $-17M | $-20M | $-12M | $-257M | $-22M | $-17M | $55M | $-12M | $-695M | $-223M | $-805M | |
| Stock Repurchased | $156M | $52M | $25M | $50M | $0 | $12M | $57M | $50M | $0 | $0 | · | · | |
| Net Stock Activity | $-156M | $-52M | $-25M | $-50M | $0 | $-12M | $-57M | $-50M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Financing Cash Flow | $-156M | $-182M | $-241M | $-186M | $-8M | $-279M | $-131M | $-249M | $-209M | $561M | $52M | $643M | |
| Net Change in Cash | $-34M | $51M | $-12M | $31M | $-5M | $-62M | $67M | $-5M | $-9M | $15M | $6M | $-7M | |
| Taxes Paid | $46M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $246M | $243M | $239M | $222M | $250M | $213M | $203M | $179M | $198M | $145M | $171M | $150M | |
| Levered FCF | · | $242M | $235M | · | · | · | · | · | · | · | · | · |
الربحية 8
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% | 58.0% | 56.9% | |
| Operating Margin | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% | 31.5% | 30.2% | 6.9% | 20.7% | 23.3% | 32.3% | 29.1% | |
| Net Margin | 17.5% | 18.9% | 18.6% | -7.3% | 18.9% | 17.5% | 14.8% | -3.7% | 32.6% | 7.9% | 12.4% | 11.0% | |
| Pretax Margin | 23.6% | 25.0% | 24.5% | -8.3% | 24.1% | 21.6% | 19.9% | -3.9% | 10.3% | 12.6% | 19.5% | 17.9% | |
| EBITDA Margin | 31.3% | 32.2% | 33.1% | 0.91% | 33.3% | 34.7% | 33.2% | 10.2% | 23.9% | 26.2% | 35.2% | 31.6% | |
| ROA | 5.5% | 6.4% | 6.3% | -2.3% | 5.8% | 4.7% | 4.1% | -0.99% | 8.8% | 2.0% | 3.6% | 3.5% | |
| ROE | 10.2% | 11.8% | 12.9% | -5.2% | 13.3% | 12.3% | 12.2% | -3.1% | 33.9% | 8.9% | 14.6% | 13.1% | |
| ROIC | 12.1% | 13.9% | 9.3% | -0.70% | 8.5% | 8.5% | 7.5% | 2.2% | 21.6% | 4.3% | 7.0% | 5.8% |
السيولة والملاءة 5
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 | 2.2 | 2.4 | 2.4 | 2.5 | 2.1 | 2.3 | 2.0 | |
| Quick Ratio | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 | 1.2 | 1.6 | 1.4 | 1.4 | 1.1 | 1.1 | 1.1 | |
| Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| LT Debt / Equity | · | · | 0.7 | 0.9 | 0.9 | 1.1 | 1.5 | 1.6 | 1.7 | 2.7 | 2.2 | 2.5 | |
| Interest Coverage | · | 187.1 | 65.9 | · | · | · | · | · | · | · | · | · |
الكفاءة 3
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 3.2 | 3.5 | 3.3 | 3.6 | 4.0 | 3.4 | 3.5 | 3.6 | 4.0 | · | · | · | |
| Receivables Turnover | 5.6 | 6.1 | 6.5 | 7.4 | 8.6 | 7.1 | 6.4 | 6.6 | 7.5 | 7.6 | 8.8 | 9.3 |
معدلات النمو 9
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.3% | 1.1% | -0.21% | 3.8% | 15.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.2% | 1.5% | 6.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.9% | 2.9% | · | · | 24.3% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 2.0% | 8.7% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -11.3% | 2.5% | · | · | 24.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 1.5% | 8.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 2.9% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 16
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943M | $963M | $976M | $1.04B | $882M | $806M | $715M | |
| Net Income TTM | $190M | $215M | $209M | $-82M | $205M | $165M | $142M | $-36M | $340M | $69M | $100M | $78M | |
| Market Cap | $3.33B | $4.82B | $4.03B | $3.44B | $2.88B | $2.38B | $1.97B | $1.61B | $1.80B | $2.96B | $2.83B | $2.25B | |
| Enterprise Value | · | · | $5.11B | $4.72B | $4.33B | $3.83B | $3.61B | $3.38B | $3.76B | $5.11B | $4.43B | $3.82B | |
| P/E | 15.2 | 20.0 | 17.4 | -38.0 | 13.1 | 13.6 | 13.2 | -43.3 | 5.3 | 42.7 | 28.4 | 28.8 | |
| P/S | 3.1 | 4.2 | 3.6 | 3.0 | 2.7 | 2.5 | 2.0 | 1.6 | 1.7 | 3.4 | 3.5 | 3.2 | |
| P/B | 1.8 | 2.6 | 2.4 | 2.4 | 1.8 | 1.8 | 1.7 | 1.5 | 1.5 | 3.6 | 3.8 | 3.6 | |
| P / Cash Flow | 12.9 | 19.1 | 16.2 | 15.0 | 11.1 | 10.1 | 9.1 | 8.5 | 8.6 | 20.0 | 16.2 | 14.4 | |
| P / FCF | 13.5 | 19.8 | 16.8 | 15.5 | 11.5 | 11.2 | 9.7 | 9.0 | 9.1 | 20.4 | 16.6 | 15.0 | |
| EV / EBITDA | · | · | 13.7 | 462.6 | 12.0 | 11.7 | 11.3 | 34.0 | 15.1 | 22.1 | 15.6 | 17.0 | |
| EV / FCF | · | · | 21.3 | 21.3 | 17.3 | 17.9 | 17.8 | 18.9 | 19.0 | 35.3 | 25.9 | 25.5 | |
| EV / Revenue | · | · | 4.5 | 4.2 | 4.0 | 4.1 | 3.7 | 3.5 | 3.6 | 5.8 | 5.5 | 5.3 | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Earnings Yield | 6.6% | 5.0% | 5.8% | -2.6% | 7.6% | 7.4% | 7.6% | -2.3% | 18.8% | 2.3% | 3.5% | 3.5% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | 0.00% | 0.00% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $0 | $0 |
قائمة الدخل 14
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $266M | $282M | $283M | $274M | $250M | $297M | $290M | $284M | $267M | $277M | $283M | $286M | $279M | $286M | $276M | $289M | |
| Cost of Revenue | $130M | $135M | $126M | $123M | $109M | $127M | $129M | $126M | $121M | $125M | $125M | $126M | $125M | $132M | $125M | $128M | |
| Gross Profit | $136M | $146M | $157M | $152M | $140M | $170M | $161M | $157M | $146M | $152M | $158M | $160M | $155M | $154M | $150M | $161M | |
| SG&A Expense | $43M | $30M | $30M | $28M | $28M | $27M | $26M | $26M | $29M | $26M | $26M | $26M | $28M | $28M | $27M | $26M | |
| Operating Expenses | $84M | $71M | $75M | $72M | $69M | $82M | $69M | $73M | $74M | $70M | $71M | $72M | $69M | $435M | $63M | $77M | |
| Operating Income | $53M | $75M | $82M | $80M | $72M | $88M | $92M | $84M | $72M | $82M | $87M | $88M | $85M | $-281M | $87M | $84M | |
| Other Non-op | $-34.0K | $708.0K | $-10M | $-501.0K | $224.0K | $-4M | $-353.0K | $-395.0K | $-496.0K | $429.0K | $-682.0K | $-229.0K | $1M | $451.0K | $-1M | $-812.0K | |
| Income Tax | $9M | $11M | $15M | $27M | $14M | $24M | $19M | $17M | $9M | $18M | $17M | $17M | $15M | $-59M | $16M | $16M | |
| Net Income | $29M | $54M | $47M | $42M | $47M | $50M | $61M | $54M | $49M | $49M | $53M | $54M | $53M | $-241M | $52M | $51M | |
| EPS (Basic) | $0.61 | $1.13 | $0.98 | $0.86 | $0.96 | $1.01 | $1.23 | $1.10 | $0.98 | $0.99 | $1.07 | $1.08 | $1.07 | $-4.82 | $1.05 | $1.02 | |
| EPS (Diluted) | $0.61 | $1.13 | $0.97 | $0.86 | $0.95 | $1.00 | $1.22 | $1.09 | $0.98 | $0.98 | $1.06 | $1.07 | $1.06 | $-4.80 | $1.04 | $1.02 | |
| Shares (Basic) | 47,462,000 | -97,924,000 | 47,880,000 | 49,025,000 | 49,475,000 | -99,438,000 | 49,597,000 | 49,652,000 | 49,886,000 | -99,437,000 | 49,740,000 | 49,687,000 | 49,767,000 | -99,872,000 | 49,693,000 | 49,804,000 | |
| Shares (Diluted) | 47,604,000 | -98,464,000 | 48,087,000 | 49,264,000 | 49,833,000 | -100,178,000 | 49,993,000 | 49,998,000 | 50,267,000 | -100,224,000 | 50,125,000 | 50,081,000 | 50,196,000 | -101,292,000 | 50,186,000 | 50,265,000 | |
| EBITDA | $61M | · | $82M | $80M | $79M | · | $92M | $84M | $80M | · | $87M | $88M | $93M | · | $87M | $84M |
الميزانية العمومية 28
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $64M | $62M | $119M | $140M | $98M | $51M | $52M | $34M | $46M | $64M | $60M | $55M | · | $86M | $42M | |
| Receivables | $187M | $192M | $190M | $199M | $168M | $194M | $167M | $164M | $172M | $177M | $174M | $158M | $158M | · | $157M | $146M | |
| Inventory | $190M | $159M | $164M | $159M | $153M | $148M | $152M | $156M | $152M | $139M | $149M | $161M | $170M | · | $159M | $141M | |
| Prepaid Expense | $30M | $17M | $17M | $20M | $19M | $8M | $8M | $9M | $11M | $13M | $7M | $8M | $9M | · | $7M | $8M | |
| Current Assets | $497M | $431M | $433M | $497M | $481M | $448M | $377M | $381M | $369M | $375M | $394M | $388M | $392M | · | $409M | $337M | |
| PP&E (Net) | $117M | $122M | $128M | $73M | $74M | $75M | $74M | $75M | $75M | $77M | $70M | $71M | $70M | · | $70M | $70M | |
| PP&E (Gross) | · | $211M | · | · | · | $156M | · | · | · | $149M | · | · | · | · | · | · | |
| Accum. Depreciation | · | $89M | · | · | · | $81M | · | · | · | $72M | · | · | · | · | · | · | |
| Goodwill | $651M | $581M | $581M | $528M | $528M | $527M | $527M | $529M | $528M | $528M | $528M | $527M | $527M | $528M | $577M | $576M | |
| Intangibles | $3.24B | $2.30B | $2.30B | $2.29B | $2.29B | $2.30B | $2.31B | $2.32B | $2.32B | $2.32B | $2.33B | $2.33B | $2.34B | · | $2.67B | $2.67B | |
| Other Non-current Assets | $13M | $11M | $4M | $3M | $3M | $3M | $6M | $7M | $6M | $6M | $6M | $4M | $3M | · | $3M | $3M | |
| Total Assets | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Accounts Payable | $37M | $23M | $43M | $42M | $22M | $19M | $20M | $31M | $40M | $39M | $39M | $44M | $58M | · | $64M | $56M | |
| Current Liabilities | $154M | $121M | $140M | $135M | $110M | $107M | $103M | $107M | $114M | $117M | $127M | $130M | $147M | · | $160M | $152M | |
| Capital Leases | $19M | $21M | $18M | $20M | $21M | $23M | $24M | $7M | $7M | $8M | $6M | $7M | $8M | · | $12M | $13M | |
| Deferred Tax | $449M | $447M | $449M | $445M | $427M | $420M | $413M | $415M | $409M | $404M | $397M | $388M | $384M | · | $456M | $443M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $9M | $9M | $9M | $8M | · | $9M | $9M | |
| Total Liabilities | $2.65B | $1.61B | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B | $1.63B | $1.66B | $1.74B | $1.80B | $1.87B | · | $2.06B | $2.06B | |
| Long-term Debt | $2.02B | $994M | $1.03B | $993M | $993M | $992M | $992M | $1.05B | $1.09B | $1.13B | $1.20B | $1.26B | $1.32B | · | $1.42B | $1.44B | |
| Total Debt | $2.02B | · | · | · | · | · | $1.00B | $1.06B | $1.10B | · | $1.21B | $1.27B | $1.33B | · | $1.44B | $1.46B | |
| Common Stock | $563.0K | $562.0K | $562.0K | $562.0K | $561.0K | $560.0K | $559.0K | $557.0K | $557.0K | $555.0K | $553.0K | $552.0K | $552.0K | · | $548.0K | $547.0K | |
| Paid-in Capital | $613M | $609M | $605M | $603M | $600M | $593M | $588M | $577M | $573M | $567M | $556M | $552M | $547M | · | $533M | $524M | |
| Retained Earnings | $1.78B | $1.75B | $1.69B | $1.65B | $1.60B | $1.56B | $1.51B | $1.44B | $1.39B | $1.34B | $1.29B | $1.24B | $1.19B | · | $1.37B | $1.32B | |
| Treasury Stock | $442M | $439M | $439M | $392M | $316M | $277M | $266M | $263M | $252M | $220M | $220M | $220M | $220M | · | $189M | $189M | |
| AOCI | $-30M | $-28M | $-30M | $-32M | $-32M | $-38M | $-40M | $-27M | $-31M | $-34M | $-29M | $-36M | $-32M | · | $-29M | $-36M | |
| Stockholders' Equity | $1.92B | $1.89B | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B | $1.68B | $1.66B | $1.60B | $1.54B | $1.48B | $1.45B | $1.69B | $1.62B | |
| Liabilities + Equity | $4.57B | $3.49B | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B | $3.34B | $3.33B | $3.35B | · | $3.75B | $3.68B | |
| Shares Outstanding | 56,312,000 | 56,211,000 | 56,198,000 | 56,196,000 | 56,171,000 | 56,010,000 | 55,939,000 | 55,769,000 | 55,717,000 | 55,501,000 | 55,329,000 | 55,291,000 | 55,220,000 | 54,857,000 | 54,852,000 | 54,690,000 |
التدفق النقدي 15
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $8M | $8M | $8M | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Stock-based Comp | $4M | $3M | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $3M | $2M | $3M | |
| Deferred Tax | $193.0K | $-4M | $4M | $17M | $6M | $7M | $3M | $4M | $612.0K | $8M | $5M | $5M | $4M | $-75M | $10M | $3M | |
| Amort. of Intangibles | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | · | $6M | $6M | |
| Other Non-cash | $29M | · | · | · | $14M | · | · | · | $-6M | · | · | · | $-21M | · | · | · | |
| Operating Cash Flow | $71M | $43M | $78M | $57M | $79M | $62M | $65M | $70M | $55M | $67M | $71M | $62M | $48M | $59M | $55M | $58M | |
| CapEx | $4M | $5M | $3M | $2M | $838.0K | $3M | $2M | $2M | $1M | $3M | $2M | $3M | $1M | $3M | $2M | $2M | |
| Investing Cash Flow | $-1.06B | $-3M | $-129M | $-3M | $-2M | $-3M | $-10M | $-2M | $-2M | $-15M | $-4M | $-3M | $2M | $-6M | $-2M | $-2M | |
| Debt Issued | $1.04B | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $1.04B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $0 | $690.0K | $46M | $75M | $35M | $11M | $2M | $12M | $26M | $0 | $0 | $0 | $25M | $0 | $0 | $12M | |
| Net Stock Activity | $0 | · | · | · | $-35M | · | · | · | $-26M | · | · | · | $-25M | · | · | · | |
| Financing Cash Flow | $1.02B | $-38M | $-7M | $-75M | $-36M | $-11M | $-54M | $-51M | $-66M | $-68M | $-65M | $-54M | $-54M | $-80M | $-10M | $-48M | |
| Net Change in Cash | $25M | $1M | $-57M | $-20M | $42M | $47M | $-666.0K | $17M | $-12M | $-17M | $4M | $5M | $-4M | $-28M | $44M | $7M | |
| Free Cash Flow | $67M | · | · | · | $78M | · | · | · | $54M | · | · | · | $47M | · | · | · |
الربحية 6
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 51.2% | · | 55.5% | 55.3% | 56.2% | · | 55.5% | 55.5% | 54.7% | · | 55.9% | 55.9% | 55.4% | · | 54.6% | 55.7% | |
| Operating Margin | 19.8% | · | 29.1% | 29.1% | 28.8% | · | 31.7% | 29.7% | 27.0% | · | 30.7% | 30.8% | 30.5% | · | 31.6% | 29.2% | |
| Net Margin | 11.0% | · | 16.5% | 15.4% | 19.0% | · | 21.0% | 19.2% | 18.4% | · | 18.8% | 18.7% | 19.1% | · | 18.9% | 17.6% | |
| EBITDA Margin | 23.1% | · | 29.1% | 29.1% | 31.8% | · | 31.7% | 29.7% | 30.0% | · | 30.7% | 30.8% | 33.2% | · | 31.6% | 29.2% | |
| ROA | 0.73% | · | 1.4% | 1.2% | 1.4% | · | 1.8% | 1.6% | 1.5% | · | 1.5% | 1.5% | 1.5% | · | 1.4% | 1.4% | |
| ROE | 1.6% | · | 2.6% | 2.4% | 2.7% | · | 3.6% | 3.3% | 3.1% | · | 3.2% | 3.4% | 3.5% | · | 3.2% | 3.3% |
السيولة والملاءة 4
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | · | 3.1 | 3.7 | 4.4 | · | 3.7 | 3.6 | 3.2 | · | 3.1 | 3.0 | 2.7 | · | 2.6 | 2.2 | |
| Quick Ratio | 1.8 | · | 1.8 | 2.4 | 2.8 | · | 2.1 | 2.0 | 1.8 | · | 1.9 | 1.7 | 1.4 | · | 1.5 | 1.2 | |
| Debt / Equity | 1.1 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| LT Debt / Equity | 1.0 | · | · | · | · | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | 0.9 | · | 0.9 | 0.9 |
الكفاءة 3
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.8 | · | 0.8 | 0.8 | 0.7 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 1.0 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.5 | 1.5 | · | 1.7 | 1.8 | 1.6 | · | 1.7 | 1.9 | 1.8 | · | 1.9 | 2.0 |
التقييم (آخر 12 شهرًا) 13
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.07B | · | $1.10B | $1.10B | $1.09B | · | $1.12B | $1.12B | $1.12B | · | $1.12B | $1.13B | $1.12B | · | $1.12B | $1.12B | |
| Net Income TTM | $166M | · | $197M | $205M | $212M | · | $218M | $210M | $209M | · | $212M | $210M | $212M | · | $208M | $202M | |
| Market Cap | $2.66B | · | $3.47B | $3.51B | $4.49B | · | $4.37B | $4.02B | $3.84B | · | $3.39B | $3.16B | $3.28B | · | $3.43B | $2.73B | |
| Enterprise Value | $4.59B | · | · | · | · | · | $5.32B | $5.03B | $4.90B | · | $4.53B | $4.38B | $4.56B | · | $4.79B | $4.14B | |
| P/E | 13.9 | · | 15.4 | 15.1 | 18.8 | · | 18.0 | 17.2 | 16.5 | · | 14.5 | 13.6 | 14.1 | · | 15.1 | 12.5 | |
| P/S | 2.5 | · | 3.2 | 3.2 | 4.1 | · | 3.9 | 3.6 | 3.4 | · | 3.0 | 2.8 | 2.9 | · | 3.1 | 2.4 | |
| P/B | 1.4 | · | 1.9 | 1.9 | 2.4 | · | 2.4 | 2.3 | 2.3 | · | 2.1 | 2.1 | 2.2 | · | 2.0 | 1.7 | |
| P / Cash Flow | 37.6 | · | · | · | 56.8 | · | · | · | 70.0 | · | · | · | 68.2 | · | · | · | |
| P / FCF | 39.7 | · | · | · | 57.4 | · | · | · | 71.5 | · | · | · | 70.4 | · | · | · | |
| EV / EBITDA | 74.9 | · | · | · | · | · | 57.8 | 59.6 | 61.1 | · | 52.2 | 49.6 | 49.1 | · | 54.9 | 49.0 | |
| EV / FCF | 68.4 | · | · | · | · | · | · | · | 91.4 | · | · | · | 97.8 | · | · | · | |
| EV / Revenue | 4.3 | · | · | · | · | · | 4.7 | 4.5 | 4.4 | · | 4.0 | 3.9 | 4.1 | · | 4.3 | 3.7 | |
| Earnings Yield | 7.2% | · | 6.5% | 6.6% | 5.3% | · | 5.6% | 5.8% | 6.1% | · | 6.9% | 7.3% | 7.1% | · | 6.6% | 8.0% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| الإيرادات | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B |
| هامش الربح الإجمالي % | 54.7% | 55.8% | 55.5% | 55.5% | 57.1% |
| هامش الربح التشغيلي % | 28.4% | 29.6% | 30.4% | -2.0% | 30.4% |
| صافي الدخل | $190M | $215M | $209M | $-82M | $205M |
| EPS المخفف | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 |
الميزانية العمومية
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | — | — | 0.7 | 0.9 | 0.9 |
| النسبة الحالية | 3.6 | 4.2 | 3.2 | 2.4 | 2.0 |
| النسبة السريعة | 2.1 | 2.7 | 1.9 | 1.4 | 1.2 |
التدفق النقدي
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $246M | $243M | $239M | $222M | $250M |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 341 مقدمي إقرار · $1.4B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 44 (-8 مقابل الربع السابق) | 68 (+27 مقابل الربع السابق) | 103 (-14 مقابل الربع السابق) | 116 (-17 مقابل الربع السابق) | +6.6M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $133553822 | 2825340 | 9,66% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $120771730 | 2554934 | 8,74% | الأسهم |
| FULLER & THALER ASSET MANAGEMENT, INC. | $110225175 | 2331821 | 7,98% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $101013343 | 2136944 | 7,31% | الأسهم |
| STATE STREET CORP | $100047570 | 2116513 | 7,24% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $65891925 | 1393741 | 4,77% | الأسهم |
| WESTWOOD HOLDINGS GROUP INC | $35473535 | 750445 | 2,57% | الأسهم |
| RICE HALL JAMES & ASSOCIATES, LLC | $32601741 | 689692 | 2,36% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $31134811 | 658659 | 2,25% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30922805 | 654174 | 2,24% | الأسهم |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $29472798 | 623499 | 2,13% | الأسهم |
| CITADEL ADVISORS LLC | $26667701 | 564157 | 1,93% | الأسهم |
| NORDEA INVESTMENT MANAGEMENT AB | $21069134 | 444778 | 1,52% | الأسهم |
| Leeward Investments, LLC - MA | $20700289 | 437916 | 1,50% | الأسهم |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $20458078 | 432792 | 1,48% | الأسهم |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $19921578 | 421440 | 1,44% | الأسهم |
| GOLDMAN SACHS GROUP INC | $18290134 | 386929 | 1,32% | الأسهم |
| Woodline Partners LP | $17004012 | 359721 | 1,23% | الأسهم |
| Boston Trust Walden Corp | $16026137 | 339034 | 1,16% | الأسهم |
| ARMISTICE CAPITAL, LLC | $15882720 | 336000 | 1,15% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $14837438 | 313887 | 1,07% | الأسهم |
| D. E. Shaw & Co., Inc. | $14832286 | 313778 | 1,07% | الأسهم |
| Glenmede Investment Management, LP | $14738755 | 236198 | 1,07% | الأسهم |
| Congress Wealth Management LLC / DE / | $13030320 | 163185 | 0,94% | الأسهم |
| PRINCIPAL FINANCIAL GROUP INC | $12652856 | 267672 | 0,92% | الأسهم |
| Tributary Capital Management, LLC | $11958554 | 252984 | 0,87% | الأسهم |
| Fisher Asset Management, LLC | $11698136 | 247474 | 0,85% | الأسهم |
| BlackRock, Inc. | $11472949 | 242711 | 0,83% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $11013816 | 232998 | 0,80% | الأسهم |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $10122871 | 214150 | 0,73% | الأسهم |
| Aristotle Capital Boston, LLC | $10043458 | 212470 | 0,73% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $9983703 | 211206 | 0,72% | الأسهم |
| FMR LLC | $9854850 | 208480 | 0,71% | الأسهم |
| GLENMEDE TRUST CO NA | $8992881 | 190245 | 0,65% | الأسهم |
| JONES FINANCIAL COMPANIES LLLP | $8876161 | 179643 | 0,64% | الأسهم |
| PRUDENTIAL FINANCIAL INC | $8336774 | 176365 | 0,60% | الأسهم |
| Public Sector Pension Investment Board | $7691065 | 162705 | 0,56% | الأسهم |
| NICHOLAS COMPANY, INC. | $7134461 | 150930 | 0,52% | الأسهم |
| JENNISON ASSOCIATES LLC | $7021487 | 148540 | 0,51% | الأسهم |
| RAYMOND JAMES FINANCIAL INC | $6817847 | 144232 | 0,49% | الأسهم |
| Nuveen, LLC | $6165662 | 130435 | 0,45% | الأسهم |
| RHUMBLINE ADVISERS | $6089432 | 128823 | 0,44% | الأسهم |
| UBS Group AG | $6044462 | 127871 | 0,44% | الأسهم |
| Man Group plc | $5627777 | 119056 | 0,41% | الأسهم |
| Clearbridge Investments, LLC | $5310029 | 112334 | 0,38% | الأسهم |
| GHP Investment Advisors, Inc. | $5256258 | 88683 | 0,38% | الأسهم |
| AMERIPRISE FINANCIAL INC | $4677273 | 98948 | 0,34% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $4631940 | 97989 | 0,34% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $4528560 | 95802 | 0,33% | الأسهم |
| Swiss National Bank | $4471742 | 94600 | 0,32% | الأسهم |
| Nuveen Asset Management, LLC | $4402324 | 56375 | 0,32% | الأسهم |
| Dana Investment Advisors, Inc. | $4397623 | 93032 | 0,32% | الأسهم |
| KING LUTHER CAPITAL MANAGEMENT CORP | $4305257 | 91078 | 0,31% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $4282898 | 90605 | 0,31% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $3798674 | 64091 | 0,27% | الأسهم |
| NORGES BANK | $3542745 | 74947 | 0,26% | الأسهم |
| Legal & General Group Plc | $3433315 | 72632 | 0,25% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3396764 | 57310 | 0,25% | الأسهم |
| KESTREL INVESTMENT MANAGEMENT CORP | $3306537 | 69950 | 0,24% | الأسهم |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $3202595 | 54034 | 0,23% | الأسهم |
| LPL Financial LLC | $2939012 | 62175 | 0,21% | الأسهم |
| FIFTH THIRD BANCORP | $2804573 | 59330 | 0,20% | الأسهم |
| WELLS FARGO & COMPANY/MN | $2513819 | 53180 | 0,18% | الأسهم |
| XTX Topco Ltd | $2510746 | 53115 | 0,18% | الأسهم |
| MARTINGALE ASSET MANAGEMENT L P | $2474112 | 52340 | 0,18% | الأسهم |
| MAVERICK CAPITAL LTD | $2409588 | 50975 | 0,17% | الأسهم |
| Emerald Investment Advisers, LLC | $2327622 | 49241 | 0,17% | الأسهم |
| DEUTSCHE BANK AG\ | $2324171 | 49168 | 0,17% | الأسهم |
| ALLSTATE CORP | $2209589 | 46744 | 0,16% | الأسهم |
| Bridgewater Associates, LP | $2193659 | 46407 | 0,16% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $2190492 | 46340 | 0,16% | الأسهم |
| OSSIAM | $2046791 | 43300 | 0,15% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $2002499 | 42363 | 0,14% | الأسهم |
| Morningstar Investment Management LLC | $1980211 | 33410 | 0,14% | الأسهم |
| BRANDES INVESTMENT PARTNERS, LP | $1969977 | 41675 | 0,14% | الأسهم |
| ROYCE & ASSOCIATES LP | $1817059 | 38440 | 0,13% | الأسهم |
| BARCLAYS PLC | $1770355 | 37452 | 0,13% | الأسهم |
| Quantinno Capital Management LP | $1623914 | 34354 | 0,12% | الأسهم |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $1554285 | 32881 | 0,11% | الأسهم |
| Voleon Capital Management LP | $1471893 | 31138 | 0,11% | الأسهم |
| JANUS HENDERSON GROUP PLC | $1338737 | 22589 | 0,10% | الأسهم |
| MetLife Investment Management, LLC | $1320677 | 27939 | 0,10% | الأسهم |
| Gotham Asset Management, LLC | $1308954 | 27691 | 0,09% | الأسهم |
| GREAT LAKES ADVISORS, LLC | $1263811 | 26736 | 0,09% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $1242965 | 26295 | 0,09% | الأسهم |
| Corient Private Wealth LP | $1201742 | 25423 | 0,09% | الأسهم |
| DAVENPORT & Co LLC | $1200374 | 25394 | 0,09% | الأسهم |
| KLP KAPITALFORVALTNING AS | $1181750 | 25000 | 0,09% | الأسهم |
| VANGUARD GROUP INC | $1170815 | 18979 | 0,08% | الأسهم |
| Nebula Research & Development LLC | $1143851 | 14325 | 0,08% | الأسهم |
| Illinois Municipal Retirement Fund | $1140058 | 24118 | 0,08% | الأسهم |
| PINNACLE ASSOCIATES LTD | $1132447 | 23957 | 0,08% | الأسهم |
| JANE STREET GROUP, LLC | $1071327 | 22664 | 0,08% | الأسهم |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1068774 | 22610 | 0,08% | الأسهم |
| SEI INVESTMENTS CO | $1050890 | 22231 | 0,08% | الأسهم |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1043580 | 22077 | 0,08% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1027366 | 21734 | 0,07% | الأسهم |
| Louisiana State Employees Retirement System | $983216 | 20800 | 0,07% | الأسهم |
| Campbell & CO Investment Adviser LLC | $906402 | 19175 | 0,07% | الأسهم |
| EASTERLY INVESTMENT PARTNERS LLC | $869768 | 18400 | 0,06% | الأسهم |
المطلعون على الشركة 50 من المطلعين · مسؤولون 29 · مديرون 18
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Ronald M. Lombardi | Chief Executive Officer | 7 مايو، 2026 F | 373465 | 0 | 0 | $0 |
| Matthew Mannelly | President and CEO | 1 يونيو، 2015 M | 27706 | 0 | 0 | $0 |
| Mark Pettie | Chairman and CEO | 3 مارس، 2009 P | 177168 | 0 | 0 | $0 |
| Frank Palantoni | CEO and President | 19 مايو، 2006 P | 33278 | 0 | 0 | $0 |
| Christine Sacco | CFO & COO | 2 مايو، 2026 F | 57374 | 0 | 0 | $0 |
| David S Marberger | Chief Financial Officer | 9 مايو، 2016 A | 11050 | 0 | 0 | $0 |
| Peter Anderson | Chief Financial Officer | 25 مايو، 2010 D | 401850 | 0 | 0 | $0 |
| Jeffrey Zerillo | Senior VP Operations | 11 مايو، 2026 S | 41810 | 0 | 7 | $-246374 |
| Adel Mekhail | EVP, Marketing & Sales | 7 مايو، 2026 F | 25703 | 0 | 0 | $0 |
| William P'Pool | SVP, General Counsel & Corp Secretary | 4 مايو، 2026 A | 28149 | 0 | 0 | $0 |
| Jose Luis Rosado | SVP-Quality & Regulatory Affairs | 6 يناير، 2026 A | 3436 | 0 | 0 | $0 |
| Mary Beth Fritz | SVP Quality & Regulatory | 7 مايو، 2025 F | 17051 | 0 | 0 | $0 |
| Timothy Connors | EVP, Sales & Marketing | 9 مايو، 2019 F | 21717 | 0 | 0 | $0 |
| Jean A Boyko | SVP, Science and Technology | 15 مايو، 2018 M | 11081 | 0 | 0 | $0 |
| Christopher Heye | Senior Vice President-Canada, Women's Health and Strategic Planning. | 7 مايو، 2018 A | 8150 | 0 | 0 | $0 |
| Thomas Hochuli | Vice President, Operations | 14 أغسطس، 2017 F | 6678 | 0 | 0 | $0 |
| John Parkinson | Senior VP- International | 12 مايو، 2017 F | 62075 | 0 | 0 | $0 |
| Paul Migaki | VP of Strategic Planning/Canada | 27 مايو، 2016 M | 55927 | 0 | 0 | $0 |
| Samuel C Cowley | General Counsel and VP | 27 مايو، 2016 M | 32176 | 0 | 0 | $0 |
| Paul A. Hennessey | Vice President, Operations | 21 مايو، 2014 M | 15282 | 0 | 0 | $0 |
| Eric S. Klee | Secretary and General Counsel | 30 مايو، 2011 F | 13236 | 0 | 0 | $0 |
| David Talbert | Senior Vice President, Sales | 25 مايو، 2010 D | 28331 | 0 | 0 | $0 |
| Lieven Nuyttens | Senior VP, Operations | 25 مايو، 2010 D | 16640 | 0 | 0 | $0 |
| Charles Jolly | Secretary and General Counsel | 31 مارس، 2009 D | 30579 | 0 | 0 | $0 |
| Charles Schrank | Chief Mktg. Officer/Household | 31 مارس، 2009 D | 90846 | 0 | 0 | $0 |
| James E Kelly | SVP - Chief Marketing Officer | 30 مايو، 2008 A | 27427 | 0 | 0 | $0 |
| Gerard Butler | Chief Sales Officer | 2 يناير، 2007 D | 289172 | 0 | 0 | $0 |
| Michael Fink | Senior V.P. of Marketing | 15 فبراير، 2005 S | 180560 | 0 | 0 | $0 |
| Eric Millar | Senior V.P. of Operations | 15 فبراير، 2005 S | 72347 | 0 | 0 | $0 |
| Sheila Hopkins | مدير | 5 أغسطس، 2025 A | 30123 | 0 | 0 | $0 |
| Natale S Ricciardi | مدير | 1 أغسطس، 2023 A | 27098 | 0 | 0 | $0 |
| COUGHLIN CHRISTOPHER J | مدير | 2 أغسطس، 2022 A | 13218 | 0 | 0 | $0 |
| James M Jenness | مدير | 4 أغسطس، 2020 A | 22791 | 0 | 0 | $0 |
| Carl J Johnson | مدير | 31 يوليو، 2018 A | 14598 | 0 | 0 | $0 |
| Charles Hinkaty | مدير | 4 أغسطس، 2015 A | 31714 | 0 | 0 | $0 |
| Patrick Lonergan | مدير | 10 ديسمبر، 2012 G | 37323 | 0 | 0 | $0 |
| John Byom | مدير | 3 أغسطس، 2010 A | 29755 | 0 | 0 | $0 |
| Vincent J Hemmer | مدير | 10 سبتمبر، 2009 J | 80410 | 0 | 0 | $0 |
| Peter Mann | مدير | 4 أغسطس، 2009 A | 447700 | 0 | 0 | $0 |
| Dick L Buell | مدير | 4 أغسطس، 2009 A | 27662 | 0 | 0 | $0 |
| David Donnini | مدير | 29 مايو، 2009 S | 0 | 0 | 0 | $0 |
| Ronald B Gordon | مدير | 5 أغسطس، 2008 A | 30352 | 0 | 0 | $0 |
| Raymond Silcock | مدير | 5 أغسطس، 2008 A | 16249 | 0 | 0 | $0 |
| John F. Kelly | — | 4 أغسطس، 2026 A | 7832 | 0 | 0 | $0 |
| James Darecca | — | 4 أغسطس، 2026 A | 9572 | 0 | 0 | $0 |
| Dawn M. Zier | — | 4 أغسطس، 2026 A | 19514 | 0 | 0 | $0 |
| Celeste A. Clark | — | 4 أغسطس، 2026 A | 16511 | 0 | 0 | $0 |
| John E Byom | — | 4 أغسطس، 2026 A | 54575 | 0 | 1 | $-178050 |
| COSTLEY GARY E | — | 4 أغسطس، 2020 A | 50200 | 0 | 0 | $0 |
| GTCR GOLDER RAUNER II LLC | — | 29 مايو، 2009 S | 0 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 89 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,90% | 268039 SH | 8 أغسطس، 2026 | يومي |
| CSMD · Professionally Managed Portfolios | 2,21% | 170357 NS | 30 إبريل، 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,31% | 41115 SH | 8 أغسطس، 2026 | يومي |
| PILL · Direxion Shares ETF Trust | 1,16% | 2662 NS | 30 إبريل، 2026 | N-PORT |
| HSMV · First Trust Exchange-Traded Fund III | 0,92% | 4952 NS | 30 إبريل، 2026 | N-PORT |
| SCOW · Pacer Funds Trust | 0,73% | 201 NS | 30 إبريل، 2026 | N-PORT |
| XSLV · Invesco Exchange-Traded Fund Trust … | 0,72% | 32765 SH | 8 أغسطس، 2026 | يومي |
| CAFG · Pacer Funds Trust | 0,66% | 2667 NS | 30 إبريل، 2026 | N-PORT |
| IHE · iShares Trust | 0,57% | 169317 SH | 8 أغسطس، 2026 | يومي |
| SMMV · iShares Trust | 0,38% | 20297 SH | 8 أغسطس، 2026 | يومي |
| SVAL · iShares Trust | 0,36% | 13943 SH | 8 أغسطس، 2026 | يومي |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,30% | 12009 NS | 31 مايو، 2026 | N-PORT |
| IJS · iShares Trust | 0,28% | 421648 SH | 8 أغسطس، 2026 | يومي |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,24% | 100520 SH | 8 أغسطس، 2026 | يومي |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,23% | 7327 NS | 30 إبريل، 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,18% | 244502 NS | 30 إبريل، 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 17679 NS | 30 إبريل، 2026 | N-PORT |
| IWN · iShares Trust | 0,17% | 444333 SH | 8 أغسطس، 2026 | يومي |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,16% | 35048 NS | 30 إبريل، 2026 | N-PORT |
| XJR · iShares Trust | 0,16% | 5605 SH | 8 أغسطس، 2026 | يومي |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,16% | 7307 SH | 8 أغسطس، 2026 | يومي |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,15% | 41965 SH | 8 أغسطس، 2026 | يومي |
| IJR · iShares Trust | 0,14% | 2892020 SH | 8 أغسطس، 2026 | يومي |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 18080 NS | 30 إبريل، 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,13% | 1302 NS | 30 إبريل، 2026 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,12% | 7482 SH | 8 أغسطس، 2026 | يومي |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 63543 SH | 8 أغسطس، 2026 | يومي |
| BKSE · BNY Mellon ETF Trust | 0,12% | 1730 NS | 30 إبريل، 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,12% | 165811 SH | 8 أغسطس، 2026 | يومي |
| EBIT · Harbor ETF Trust | 0,11% | 222 NS | 30 إبريل، 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,10% | 21588 NS | 31 مايو، 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,10% | 42383 NS | 30 إبريل، 2026 | N-PORT |
| SAA · ProShares Trust | 0,10% | 567 NS | 31 مايو، 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,09% | 211016 NS | 30 إبريل، 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,09% | 50344 NS | 31 مايو، 2026 | N-PORT |
| IWM · iShares Trust | 0,08% | 1224874 SH | 8 أغسطس، 2026 | يومي |
| RSSL · Global X Funds | 0,08% | 20806 NS | 30 إبريل، 2026 | N-PORT |
| VFMV · VANGUARD WELLINGTON FUND | 0,08% | 7246 SH | 8 أغسطس، 2026 | يومي |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 28489 SH | 8 أغسطس، 2026 | يومي |
| ISCV · iShares Trust | 0,07% | 9565 SH | 8 أغسطس، 2026 | يومي |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,07% | 175325 SH | 8 أغسطس، 2026 | يومي |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 275721 SH | 8 أغسطس، 2026 | يومي |
| FNDA · SCHWAB STRATEGIC TRUST | 0,07% | 130638 NS | 31 مايو، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,07% | 163429 NS | 30 إبريل، 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 2261 NS | 31 مايو، 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 6035 SH | 8 أغسطس، 2026 | يومي |
| VBR · VANGUARD INDEX FUNDS | 0,05% | 690582 SH | 8 أغسطس، 2026 | يومي |
| SMLF · iShares Trust | 0,05% | 38128 SH | 8 أغسطس، 2026 | يومي |
| IGRO · iShares Trust | 0,05% | 10967 SH | 8 أغسطس، 2026 | يومي |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 226753 NS | 31 مايو، 2026 | N-PORT |